| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |